Organization
James Graham Brown Cancer Center
7 abstracts
Abstract
Single institution retrospective review of patients with metastatic hormone receptor positive breast cancer receiving first line therapy of CDK4/6 inhibitors.Org: James Graham Brown Cancer Center,
Abstract
Use of immunotherapy with check point inhibitors in soft tissue sarcoma: Analysis from single institution.Org: University of Louisville, James Graham Brown Cancer Center,
Abstract
Comparing overall survival in patients with metastatic prostate cancer using PSA levels: A multivariate analysis using a national database.Org: Brown Cancer Center, James Graham Brown Cancer Center, University of Louisville,
Abstract
Impact of novel pan-RAS inhibitors on efficacy and resistance to AMG-510 and MRTX-1133 in pancreatic cancer cell lines.Org: Qualigen Therapeutics, Dept. Medicine, Brown Cancer Center University of Louisville, Departments of Medicine and Pharmacology & Toxicology, James Graham Brown Cancer Center,
Abstract
Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy.Org: University of Louisville, University of Louisville School of Medicine, James Graham Brown Cancer Center,
Abstract
Tolerability and response of palliative radiotherapy in patients receiving tumor-infiltrating lymphocyte therapy.Org: School of Medicine, Zhejiang University, Hangzhou, China, University of Louisville, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Brown Cancer Center, Tufts University Medical Center,
Abstract
Circulating tumor DNA detection as a prognostic tool in patients with localized colon cancer: A systematic review and meta-analysis.Org: University of Louisville Hospital, University of Louisville, James Graham Brown Cancer Center,